Cyclin-dependent kinase inhibitor 2B gene is associated with the sensitivity of hepatoma cells to Sorafenib
Xie Weng,* Lixian Zeng,* Feifei Yan, Mengxue He, Xiuqiong Wu, Dayong ZhengDepartment of Cancer Center,TCM-Integrated Hospital of Southern Medical University, Guangzhou, Guangdong Province 510310, People’s Republic of China*These authors contributed equally to this work Purpose: The sensiti...
Main Authors: | Weng X, Zeng L, Yan F, He M, Wu X, Zheng D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-06-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/cyclin-dependent-kinase-inhibitor-2b-gene-is-associated-with-the-sensi-peer-reviewed-article-OTT |
Similar Items
-
Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
by: Gaia Giannone, et al.
Published: (2019-05-01) -
Sorafenib in the treatment of advanced hepatocellular carcinoma
by: Mousa Ali
Published: (2008-01-01) -
Cyclin-dependent kinase inhibitors: efficacy and safety
by: I. B. Kononenko, et al.
Published: (2019-06-01) -
Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma
by: Yu-Yun Shao, et al.
Published: (2019-09-01) -
Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
by: Sojung Han, et al.
Published: (2020-07-01)